The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses

M Rincón, RA Flavell, RA Davis - Free Radical Biology and Medicine, 2000 - Elsevier
The mitogen-activated protein (MAP) kinase family members, which include the extracellular
response kinases (ERK), p38, and c-Jun amino terminal kinases (JNK), play a role in …

1 p38 MAP kinase: molecular target for the inhibition of pro-inflammatory cytokines

JL Adams, AM Badger, S Kumar, JC Lee - Progress in medicinal chemistry, 2001 - Elsevier
Publisher Summary This chapter discusses that the network of immune and inflammatory
responses is comprised of a variety of cell types. Coordination of this network occurs through …

[HTML][HTML] Interferon‐γ expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway

M Rincon, H Enslen, J Raingeaud, M Recht… - The EMBO …, 1998 - embopress.org
Signal transduction via MAP kinase pathways plays a key role in a variety of cellular
responses, including growth factor‐induced proliferation, differentiation and cell death. In …

Role of p38 mitogen-activated protein kinase in a murine model of pulmonary inflammation

JA Nick, SK Young, KK Brown, NJ Avdi… - The Journal of …, 2000 - journals.aai.org
Early inflammatory events include cytokine release, activation, and rapid accumulation of
neutrophils, with subsequent recruitment of mononuclear cells. The p38 mitogen-activated …

Disease‐modifying activity of SB 242235, a selective inhibitor of p38 mitogen‐activated protein kinase, in rat adjuvant‐induced arthritis

AM Badger, DE Griswold, R Kapadia… - … : Official Journal of …, 2000 - Wiley Online Library
Objective To evaluate the effects of SB 242235, a potent and selective inhibitor of p38
mitogen‐activated protein (MAP) kinase, on joint integrity in rats with adjuvant‐induced …

[HTML][HTML] The novel JAK-3 inhibitor CP-690550 is a potent immunosuppressive agent in various murine models

E Kudlacz, B Perry, P Sawyer, M Conklyn… - American Journal of …, 2004 - Elsevier
JAK-3 has been shown to play a key role in cytokine signaling via γc, eg IL-2, 4, 7, 9, 15, 21.
The current study describes the immunosuppressive effects of CP-690550, a novel, small …

JNK and p38 MAP kinases in CD4+ and CD8+ T cells

M Rincón, G Pedraza‐Alva - Immunological reviews, 2003 - Wiley Online Library
The c‐Jun aminoterminal kinase (JNK) and p38 mitogen‐activated protein (MAP) kinase
signaling pathways have been associated with cell death, differentiation and proliferation …

Selective suppression of neutrophil accumulation in ongoing pulmonary inflammation by systemic inhibition of p38 mitogen-activated protein kinase

JA Nick, SK Young, PG Arndt, JG Lieber… - The Journal of …, 2002 - journals.aai.org
The p38 mitogen-activated protein kinase (MAPK) signaling pathway regulates a wide range
of inflammatory responses in many different cells. Inhibition of p38 MAPK before exposing a …

Oral treatment options for degenerative joint disease—presence and future

J Steinmeyer, YT Konttinen - Advanced drug delivery reviews, 2006 - Elsevier
Alleviation of pain and inhibition of inflammation are the primary goals of pharmacotherapy
of osteoarthritis (OA). These therapeutic goals can almost always be accomplished by the …

Characterization of YM-58483/BTP2, a novel store-operated Ca2+ entry blocker, on T cell-mediated immune responses in vivo

K Ohga, R Takezawa, Y Arakida, Y Shimizu… - International …, 2008 - Elsevier
YM-58483/BTP2 is a blocker of store-operated Ca2+ entry (SOCE), which regulates the
activation of non-excitable cells such as lymphocytes. YM-58483 has been reported to …